Study platelets in brain and spinal tumors
Part of Brain & nervous system, Cancer clinical trials.
This study looks at how blood “platelets” may be involved in brain or spinal (medullary) tumors by testing tumor tissue taken during surgery or biopsy. It may help researchers understand disease biology and guide future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (over 18 years old)
- You are scheduled to have a brain or spinal (medullary) tumor removed or biopsied
- You can agree in writing to take part in the study
- You are covered by the Social Security system
- The tumor tissue sample will be large enough for extra lab tests
- You are not pregnant and not breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies newly diagnosed or progressing brain tumors (grade 2–4 gliomas) to better understand the disease using tumor tissue and blood samples. It may help doctors learn which treatments could work best for different tumor types by matching tumor material to blood results.
This study is for people with a brain tumor called glioblastoma who are about to have surgery. Researchers want to find markers in your body that may help predict how the tumor behaves.
This trial checks whether a special blood test can help identify glioma (a type of brain tumor) that is new or coming back. It may help doctors learn more about the tumor using blood, alongside the usual brain scans and planned surgery.
This study looks at how brain tumors look on MRI and what biopsy tissue shows, using samples taken during planned surgery. It may help improve understanding of tumor biology and future treatment planning.
This trial studies whether a blood test can track the progress of a type of brain tumor called a grade 4 diffuse glioma. It may offer a less invasive way to monitor these tumors after surgery.
This trial looks at the genetic and molecular features of brain lesions to better understand them. It may help find new ways to diagnose or treat these conditions.
Hear when a new Glioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.